“Lower Drug Costs Now Act of 2019” Could Harm Patients
A new analysis of the Lower Drug Costs Now Act of 2019 (H.R. 3) by the Council of Economic Advisers (CEA) estimates that, if passed, the legislation could lead to a loss of as many as 100 new drugs in the U.S. over the next decade. “Congress should not set up price controls that will […]
